ObvioHealth logo
Verified via Expert Interviews

ObvioHealth: Revenue, Valuation & Competitors

ObvioHealth company overview

Ownership
VC-backed
Employees
83
Investors
SPRIM Global Investments
Revenue / FTE
$6•k

About

Clinical trial management platform for pharmaceutical, biotech, and healthcare organizations to manage study design, participant engagement, data capture, and trial operations across decentralized and hybrid research settings.
USA
Global
Verified via Expert Interviews

Expert Vetted Data

Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former ObvioHealth executives.

Ownership & Key Financials

Revenue

$5m '••
2

Investors

SPRIM Global Investments
'21
1

Revenue / FTE

$6•k '••
2

Ownership

VC-backed
1

FTEs

2
+24% CAGR
28
2020
78
2021
137
2022
157
2023
83
2024

Legal Disclaimer

The company profiles displayed here are abridged, indicative previews of the full, proprietary data available within the Dialectica Origin Platform, derived from confidential sources and expert-vetted research. This content is the exclusive Intellectual Property (IP) of Dialectica. Your access does not grant any rights to the data. Systematic copying, scraping, crawling, indexing, or extraction, whether by manual means, automated software, bots, or Large Language Models (LLMs), is strictly prohibited and violates our Terms of Use.

This information is provided 'as is' for promotional purposes only; Dialectica disclaims all liability for its accuracy, completeness, or any reliance placed upon it.